Osaic Holdings
TXG icon

Osaic Holdings’s 10x Genomics TXG Stock Holding History

Osaic Holdings’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.47M Buy
221,040
+186,120
+533% +$4.88M 0.01% 1151
2026
Q1 		$741K Sell
34,920
-148,443
-81% -$2.97M ﹤0.01% 2978
2025
Q4 		$2.99M Buy
183,363
+25,462
+16% +$385K ﹤0.01% 1768
2025
Q3 		$1.83M Sell
157,901
-5,181
-3% -$67.6K ﹤0.01% 2248
2025
Q2 		$1.89M Sell
163,082
-142,564
-47% -$1.3M ﹤0.01% 1955
2025
Q1 		$2.67M Buy
305,646
+141,398
+86% +$1.78M 0.01% 1445
2024
Q4 		$2.34M Sell
164,248
-31,171
-16% -$492K 0.01% 1543
2024
Q3 		$4.41M Buy
195,419
+14,271
+8% +$295K 0.01% 1122
2024
Q2 		$3.52M Buy
181,148
+157,386
+662% +$4.12M 0.01% 1240
2024
Q1 		$892K Buy
23,762
+7,197
+43% +$316K ﹤0.01% 2450
2023
Q4 		$927K Buy
16,565
+726
+5% +$31.6K ﹤0.01% 2595
2023
Q3 		$653K Sell
15,839
-34,336
-68% -$1.79M ﹤0.01% 3021
2023
Q2 		$2.8M Buy
50,175
+19,580
+64% +$1.06M 0.01% 1595
2023
Q1 		$1.7M Buy
30,595
+16,906
+124% +$789K ﹤0.01% 1961
2022
Q4 		$499K Buy
13,689
+2,592
+23% +$84.7K ﹤0.01% 3014
2022
Q3 		$315K Sell
11,097
-873
-7% -$33.3K ﹤0.01% 3337
2022
Q2 		$543K Sell
11,970
-892
-7% -$46.3K ﹤0.01% 2846
2022
Q1 		$916K Sell
12,862
-552
-4% -$48.3K ﹤0.01% 2662
2021
Q4 		$2M Buy
13,414
+1,080
+9% +$165K ﹤0.01% 1784
2021
Q3 		$1.79M Sell
12,334
-8,927
-42% -$1.53M ﹤0.01% 1806
2021
Q2 		$4.16M Buy
21,261
+11,398
+116% +$2.06M 0.01% 1151
2021
Q1 		$1.79M Sell
9,863
-8,974
-48% -$1.55M ﹤0.01% 1721
2020
Q4 		$2.67M Sell
18,837
-195
-1% -$28.3K 0.01% 1234
2020
Q3 		$2.37M Buy
19,032
+16,062
+541% +$1.69M 0.01% 1202
2020
Q2 		$265K Buy
2,970
+59
+2% +$4.59K ﹤0.01% 2888
2020
Q1 		$181K Buy
+2,911
New +$227K ﹤0.01% 2964

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Osaic Holdings's TXG Position: Q2 2026 in Review

Osaic Holdings increased its 10x Genomics (TXG) stake by 533% in Q2 2026, buying an estimated $4.88M and bringing the position to 221,040 shares worth $8.47M. The position accounts for 0.01% of the portfolio, ranked #1151.

Osaic Holdings first reported a position in TXG in Q1 2020 and has held it in 26 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Osaic Holdings held 221,040 shares of 10x Genomics worth $8.47M as of Q2 2026.
  • Osaic Holdings bought 186,120 10x Genomics shares in Q2 2026, an estimated $4.88M.
  • 10x Genomics made up 0.01% of Osaic Holdings's portfolio in Q2 2026, its #1151 holding.
  • Osaic Holdings first reported a position in 10x Genomics in Q1 2020 and has held it in 26 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.